Merriman Curhan Ford Acted as Placement Agent in GenVec’s $28 Million Registered Offering

Merriman Curhan Ford (Nasdaq: MERR) acted as a placement agent in GenVec, Inc.’s (Nasdaq: GNVC) $28 million registered offering of 14 million shares of common stock, and warrants to purchase 4.2 million shares of common stock,  to certain institutional investors. The transaction closed today.

“We have been working with the Merriman team for several years and appreciate their continued efforts in advising GenVec on its financing activities,” said Douglas Swirsky, Chief Financial Officer of GenVec.

The pricing of the offering was announced on January 27, 2010 by GenVec. Details on the transaction can be found at GenVec’s Web site: www.genvec.com.

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec’s lead product, TNFerade™, is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. [Read the full article]

{loadposition in-article}

Sunoco Logistics Partners L.P. (NYSE: SXL) (the “Partnership”) today announced the commencement of a public offering of 2,200,000 common units owned by its general partner, Sunoco Partners LLC, an indirect wholly-owned subsidiary of Sunoco, Inc.  The underwriters have been granted an option to purchase up to 330,000 additional common units.  

The Partnership will not receive any of the proceeds from this offering and the Partnership’s number of outstanding units will remain unchanged. The offering will be made under the Partnership’s effective shelf registration statement on Form S-3, as amended, filed with the Securities and Exchange Commission.

Barclays Capital, Citi, Credit Suisse and Wells Fargo Securities are acting as joint book-running managers for the common unit offering. [Read the full article]

Fitch Ratings has affirmed HCA Inc.’s (HCA) credit ratings as follows:

The Rating Outlook is Stable. Total rated debt at Sept. 30, 2009, was approximately $26.9 billion.

The rating action follows HCA’s announced special dividend of $1.75 billion payable to shareholders. Fitch expects the special dividend to be funded by cash on hand and borrowings from the company’s $2 billion senior secured asset-based revolving credit facility and $2 billion senior secured revolving credit facility, both maturing in November 2012. Despite the expected rise in total debt and compression of liquidity from credit facilities borrowings, Fitch believes HCA’s credit profile will remain consistent with the current rating category. [Read the full article]

Fushi Copperweld, Inc. (the “Company”) (Nasdaq: FSIN), a leading global manufacturer and innovator of copper-clad bimetallic wire used in a variety of telecommunication, utility, transportation and other electrical applications, today announced it has closed its previously announced public offering of 6,500,000 shares of its common stock at a price of $8.00 per share. On January 28, 2010, Jefferies & Company, Inc., acting as the sole book-running manager of the offering, exercised in full its over-allotment option to purchase an additional 975,000 shares of common stock. The exercise of the option increased the size of the offering to an aggregate of 7,475,000 shares of common stock.

{loadposition in-article-zecco-small}

The Company received proceeds, net of offering expenses and underwriting discounts and commissions, of approximately $55.4 million. [Read the full article]

You may also like...